| Literature DB >> 15876221 |
L Rodák1, B Smíd, Z Nevoránková, L Valícek, R Smítalová.
Abstract
Monoclonal antibodies (mAb) to the transmissible gastroenteritis virus (TGEV) nucleoprotein (N) and membrane protein (M) were prepared and used for the comparative assessment of three blocking ELISA variants to detect TGEV. The competitive blocking ELISA format showed the highest sensitivity, allowing detection of 10(3) TCID50 TGEV/ml in culture medium. Ninety-nine porcine field faecal samples obtained from 37 herds affected with diarrhoea were examined, and various TGEV levels were found in nine samples from six herds. However, only in three samples were significant TGEV concentrations demonstrated. The relationship between incidence of TGEV gastroenteritis and the spread of porcine respiratory coronavirus infection in pig farms is discussed.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15876221 PMCID: PMC7165557 DOI: 10.1111/j.1439-0450.2005.00829.x
Source DB: PubMed Journal: J Vet Med B Infect Dis Vet Public Health ISSN: 0931-1793
Figure 1Western blot analysis of TGEV antibodies. After separation in 12% polyacrylamide gel, purified TGEV and a low molecular weight standard (LMW) were transferred to a nitrocellulose membrane. A part of the membrane with the LMW standard was stained with colloidal gold (lane 1). The other lanes with TGEV were incubated with swine antisera to TGEV (lanes 2 and 3), mAbTGEV D3/G6 (lane 5), D7/G7 (lane 6), B7/F7 (lane 7) or with diluting solution alone (lanes 4 and 8). After incubation with peroxidase conjugates to swine (lanes 2–4) and mouse (lanes 5–8) immunoglobulins, the reaction was visualised by incubation in a substrate solution containing chromogen DAB. The localization of TGEV antigens S, N and M is indicated.
Figure 2Detection of TGEV in infected cells by immunoperoxidase test. Direct immunoperoxidase detection of TGEV in a cell line PK‐15 12 hpi using the conjugate HRPO‐mAbTGEV D7/G7. Intensive staining of the cytoplasm proves propagation of TGEV in infected cells.
CB‐ELISA detection of mAb reactivity with TGEV strains
| mAb TGEV | TGEV strain | ||||
|---|---|---|---|---|---|
| Shizuoka | Purdue | Cz‐1970 | Cz‐1995 | V‐344 | |
| D7/G7 | |||||
| A |
|
|
|
|
|
| NA |
|
|
|
|
|
| %B |
|
|
|
|
|
| B7/F7* | |||||
| A |
|
|
|
| 1.281/0.773 |
| NA |
|
|
|
| 0.508 |
| %B |
|
|
|
| 39.7 |
| D3/G6 | |||||
| A | 0.023/0.006 | 0.033/0.011 | 0.017/0.002 |
|
|
| NA | 0.017 | 0.022 | 0.015 |
|
|
| %B | 73.9 | 66.7 | 88.2 |
|
|
| B4/F2 | |||||
| A | 0.128/0.034 | 0.141/0.045 | 0.106/0.021 |
|
|
| NA | 0.094 | 0.096 | 0.085 |
|
|
| %B | 73.4 | 68.1 | 80.2 |
|
|
| mAb mix | |||||
| A |
|
|
|
|
|
| NA |
|
|
|
|
|
| %B |
|
|
|
|
|
A, average absorbances obtained in wells containing SwSneg./pos; NA, net absorbance; %B, percentage of the reaction blocking in wells incubated with SwSpos; mAb mix, mixture of equal concentrations (w/v) of individual mAb.
Positive A, NA and %B values are given in bold.
The culture medium of the strain V‐344 was frozen 48 hpi (after development of CPE) and examined at working dilution 1 : 4. The remaining media were frozen 24 hpi (before CPE) and examined diluted 1 : 2.
*The culture medium of the strain V‐344 incubated with mAb B7/F7 was clearly positive when diluted 1 : 8 and 1 : 16 with the A, NA and %B values 0.992/0.379, 0.613 and 61.8%, and 0.415/0.095, 0.314 and 76.8% respectively.
Detection of TGEV in a faecal sample of an experimentally infected piglet 24 hpi using three variants of monoclonal blocking ELISA methods
| ELISA variant | Absorbances and % of blocking obtained with different dilutions of faces and swine sera | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Faeces dilution | SwS dilution 20× | SwS dilution 100× | |||||||
| Neg. | Pos. | NA | %B | Neg. | Pos. | NA | %B | ||
| 1 DAS‐ELISA *mAbTGEV †HRPO‐mAbTGEV | 2× |
|
|
|
| 0.334 | 0.264 | 0.070 | 21.0 |
| 10× |
|
|
|
|
|
|
|
| |
| 50× |
|
|
|
|
|
|
|
| |
| 250× | 0.142 | 0.058 | 0.084 | 59.2 | 0.054 | 0.049 | 0.005 | 9.3 | |
| 2 CB‐ELISA *SwATGEV †HRPO‐SwAMoIg | 2× |
|
|
|
| 1.309 | 1.049 | 0.260 | 19.9 |
| 10× |
|
|
|
|
|
|
|
| |
| 50× |
|
|
|
|
|
|
|
| |
| 250× | 0.032 | 0.018 | 0.014 | 43.7 |
|
|
|
| |
| 3 DAS‐ELISA *SwATGEV †HRPO‐mAbTGEV | 2× | 1.743 | 0.873 | 0.870 | 49.9 | 1.573 | 1.314 | 0.259 | 16.5 |
| 10× |
|
|
|
| 1.543 | 0.829 | 0.714 | 46.3 | |
| 50× |
|
|
|
|
|
|
|
| |
| 250× | 0.142 | 0.073 | 0.069 | 48.6 |
|
|
|
| |
Dilutions of samples with positive values NA (>0.1) and %B (>50.0) are given in bold.
NA, net absorbance. Differences of mean absorbances in wells incubated with SwSneg./pos.
%B, % of absorbance blocking in the wells incubated with SwSpos. in comparison with the wells incubated with SwSneg.
*Binding antibodies.
†Detection antibodies (conjugate) used in respective blocking ELISA method variants.
Detection of TGEV in faecal samples obtained between 1 and 7 days after experimental infection. The influence of faecal sample dilutions on the CB‐ELISA results
| Faeces (dpi) | Faeces dilution 2× | Faeces dilution 10× | Faeces dilution 50× | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SwS neg. | SwS pos. | NA | %B | SwS neg. | SwS pos. | NA | %B | SwS neg. | SwS pos. | NA | %B | |
| 1 | 1.410 | 0.727 | 0.683 | 48.4 |
|
|
|
|
|
|
|
|
| 2 | 1.423 | 0.896 | 0.527 | 37.0 |
|
|
|
|
|
|
|
|
| 3 | 1.330 | 1.137 | 0.193 | 14.5 |
|
|
|
|
|
|
|
|
| 4 | 1.083 | 0.910 | 0.173 | 16.0 |
|
|
|
|
|
|
|
|
| 5 | 1.075 | 0.769 | 0.306 | 28.5 |
|
|
|
|
|
|
|
|
| 6 | 1.139 | 0.724 | 0.415 | 36.4 |
|
|
|
|
|
|
|
|
| 7 |
|
|
|
|
|
|
|
|
|
|
|
|
dpi, The day post‐infection.
CB‐ELISA examination was performed at various working dilutions of faecal samples (2×, 10×, 50×) and constant dilutions of SwSneg./pos. (40×), mAbTGEV mixture (10 000×) and HRPO‐SwAMoIg (10 000×).
Samples with positive NA (>0.1) and %B (>50.0) values are given in bold.